Barclays PLC Durect Corp Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.38 - $0.64 $13,361 - $22,503
-35,161 Reduced 95.73%
1,567 $1,000
Q1 2022

May 16, 2022
SELL
$0.55 - $0.98 $130,823 - $233,103
-237,861 Reduced 86.62%
36,728 $25,000
Q4 2021

Feb 14, 2022
BUY
$0.9 - $1.31 $144,553 - $210,405
160,615 Added 140.92%
274,589 $270,000
Q3 2021

Nov 09, 2021
BUY
$1.21 - $1.61 $102,241 - $136,040
84,497 Added 286.65%
113,974 $147,000
Q2 2021

Aug 13, 2021
SELL
$1.6 - $2.02 $251,153 - $317,081
-156,971 Reduced 84.19%
29,477 $48,000
Q1 2021

May 13, 2021
BUY
$1.86 - $2.87 $223,616 - $345,042
120,224 Added 181.54%
186,448 $369,000
Q4 2020

Feb 11, 2021
SELL
$1.65 - $2.43 $43,782 - $64,480
-26,535 Reduced 28.61%
66,224 $137,000
Q3 2020

Nov 12, 2020
SELL
$1.6 - $2.35 $25,270 - $37,115
-15,794 Reduced 14.55%
92,759 $158,000
Q2 2020

Aug 12, 2020
BUY
$1.33 - $2.76 $144,375 - $299,606
108,553 New
108,553 $252,000
Q1 2020

May 13, 2020
SELL
$0.97 - $2.85 $48,500 - $142,500
-50,000 Closed
0 $0
Q4 2019

Feb 10, 2020
BUY
$1.69 - $3.8 $79,916 - $179,694
47,288 Added 1743.66%
50,000 $190,000
Q3 2019

Nov 14, 2019
BUY
$0.61 - $2.21 $666 - $2,415
1,093 Added 67.51%
2,712 $5,000
Q2 2019

Aug 14, 2019
SELL
$0.51 - $0.86 $21,815 - $36,787
-42,776 Reduced 96.35%
1,619 $1,000
Q1 2019

May 15, 2019
BUY
$0.51 - $0.82 $22,591 - $36,324
44,298 Added 45668.04%
44,395 $28,000
Q4 2018

Feb 14, 2019
SELL
$0.48 - $1.1 $28,202 - $64,631
-58,756 Reduced 99.84%
97 $0
Q3 2018

Nov 14, 2018
BUY
$1.06 - $1.69 $49,733 - $79,291
46,918 Added 393.11%
58,853 $65,000
Q2 2018

Aug 14, 2018
SELL
$1.56 - $2.51 $37,302 - $60,019
-23,912 Reduced 66.71%
11,935 $18,000
Q1 2018

May 15, 2018
BUY
$0.91 - $2.24 $10,743 - $26,445
11,806 Added 49.11%
35,847 $76,000
Q4 2017

Feb 14, 2018
BUY
$0.78 - $2.1 $12,310 - $33,144
15,783 Added 191.12%
24,041 $22,000
Q3 2017

Nov 14, 2017
BUY
$1.55 - $1.82 $12,799 - $15,029
8,258
8,258 $15,000

Others Institutions Holding DRRX

# of Institutions
3
Shares Held
593K
Call Options Held
0
Put Options Held
0
View Full List

About DURECT CORP

DRRX Quotes by TradingView
  • Ticker DRRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 227,794,000
  • Market Cap $180M
  • Description
  • DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...
More about DRRX
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email